Bristol Myers director granted deferred share units

Bristol Myers Squibb director Peter J. Arduini received a grant of deferred share units tied to company stock.

Rhea-AI Filing Summary

Bristol Myers Squibb director Peter J. Arduini received a grant of deferred share units tied to company stock. He acquired 607.428 Deferred Share Units at an assigned value of $57.62 per unit, each corresponding to one share of common stock.

These units will convert into common stock when he ceases to be a director or on a future date he previously selected. Following this grant, his deferred share unit balance is 72,815.595, including deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Insider Trade Summary

Grant/Award: 607.428 shares

Grant/Award 1 txn

Insider Arduini Peter J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	607.428	$57.62	$35K

Holdings After Transaction: Deferred Share Units — 72,815.595 contracts (Direct)

Footnotes (2)

1. F1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
2. F2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Key Figures

Deferred Share Units granted: 607.428 units Grant value per unit: $57.62 per unit Deferred units after transaction: 72,815.595 units +1 more

4 metrics

Deferred Share Units granted 607.428 units Grant on 2026-06-30

Grant value per unit $57.62 per unit Assigned value for Deferred Share Units

Deferred units after transaction 72,815.595 units Total Deferred Share Units following grant

Underlying common stock 607.428 shares Shares of common stock underlying new units

Key Terms

Deferred Share Units, settlement, 1987 Deferred Compensation Plan for Non-Employee Directors, dividends reinvested

4 terms

Deferred Share Units financial

"Each Deferred Share Unit will be converted into a share of common stock upon settlement."

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

settlement financial

"The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

1987 Deferred Compensation Plan for Non-Employee Directors financial

"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."

dividends reinvested financial

"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bristol Myers Squibb (BMY) director Peter J. Arduini report on this Form 4?

Peter J. Arduini reported receiving 607.428 Deferred Share Units as a grant. Each unit tracks Bristol Myers Squibb common stock and is part of his director compensation rather than an open-market stock purchase or sale.

How many Bristol Myers (BMY) deferred share units does Arduini hold after this transaction?

After the grant, Peter J. Arduini holds 72,815.595 Deferred Share Units. This total includes deferred compensation and dividends reinvested under the company’s 1987 Deferred Compensation Plan for Non-Employee Directors.

At what value were the new Bristol Myers (BMY) Deferred Share Units awarded to Arduini?

The 607.428 Deferred Share Units were awarded at an assigned value of $57.62 per unit. This value is used for the grant calculation and reflects compensation, not a cash transaction in the open market.

When will Arduini’s Bristol Myers (BMY) Deferred Share Units convert into common stock?

Each Deferred Share Unit will convert into one share of common stock upon settlement. Settlement occurs when Arduini ceases to be a director or on a future date he previously specified under the plan’s terms.

What plan governs Arduini’s Bristol Myers (BMY) Deferred Share Units and related reinvested dividends?

The units are held under the 1987 Deferred Compensation Plan for Non-Employee Directors. His reported balance includes both deferred compensation and dividends that have been reinvested into additional Deferred Share Units under this plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arduini Peter J

(Last) (First) (Middle)

BRISTOL-MYERS SQUIBB COMPANY

ROUTE 206 AND PROVINCE LINE ROAD

(Street)

PRINCETON NEW JERSEY 08543

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	06/30/2026		A		607.428		(1)	(1)	Common Stock, $0.10 par value	607.428	$57.62	72,815.595(2)	D

Explanation of Responses:

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Remarks:

	/s/ Amy Fallone, attorney-in-fact for Peter J. Arduini	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)